ARCHIVES

DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo”

This article is from The Cancer Letter archive.

Vol. 07 No. 12 | March 20, 1981

Download PDF Visit The Full Archive

Related Articles

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

Funding Opportunities

October 18, 2002

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

Three Nurse Awards Made In Self Care

September 30, 1988